News
Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...
US biotech Capricor Therapeutics today revealed receipt of a Complete Response Letter (CRL) from the US Food and Drug ...
Brazil scrambled to craft a measured but strong response to US President Donald Trump’s surprise tariff hike on Thursday in ...
Eli Lilly (NYSE: LLY) led the way in pharma M&A during June. The US pharma major announced two major deals in the month, both ...
PLC, based on Brackla Industrial Estate in Bridgend, has secured three new patents in the United States and Europe. It has ...
1dOpinion
Al Jazeera on MSNTrump’s tariff threat to Brazil is a gift to LulaBy attacking Brazil’s sovereignty, Trump may have handed the leftist president a political and diplomatic opportunity.
The US court also barred the Viljoens from using the Tammy Taylor name and logos as well as the products in their nail salons ...
Recently, the United States has witnessed an intense legal and commercial confrontation between major pharmaceutical ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.
Continuing last week’s letter from Alec to Mabel, legal matters had progressed exceedingly well with the telephone patent suit against Western Union. As Alec wrote, their lawyer had opted to base the ...
Verona Pharma plc (NASDAQ:VRNA) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
Marc Filippino Like really big tariffs. Donald Trump voice clip If they have to bring the pharmaceuticals into the country, the drugs and other things into the country, they’re gonna be tariffed at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results